3 курс / Фармакология / Voinov_Efferentnaya_terapia_-_5_redaktsia

401

James O.F.W. Parenchymal liver disease in the elderly // Gut. - 1997. - Vol. 41, № 4. - P. 430-432.

Jander S., Bischoff J. Treatment of Amanita Phalloides poisoning: I. Retrospective evaluation of plasmapheresis in 21 patients // Ther. Apher. – 2000. – Vol. 4, № 4. – P. 303-307.

Jaramillo A., Smith M.A., Phelan D. et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation // Transplantation. – 1999. – Vol. 67, № 8. – P. 1155-1161.

Jaramillo A., Fernandez F.G., Kuo E.Y. et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation // Pediatr. Transplant. – 2005. – Vol. 9, № 1. – P. 84-93.

Jensen M., Schröder J., Blomberg M. et al. Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer’s disease and declines with disease progression // Ann. Neurol. - 1999. - Vol. 45, № 4. - P. 504-511.

Jiang X., Lu M., Ying Y et al. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria // Ther. Apher. Dial. – 2008. – Vol. 12, № 6.

– P. 505-508.

Jobe A.H., Newnham J., Willet K. et al. Fetal versus maternal and gestational age effects of repititive antenatal glucocorticoids // Pediatrics. – 1998. – Vol. 102, № 5. – P. 1116-1125.

Jones J. Apheresis in the treatment of SLE // In: Therapeutic Hemapheresis: Wichtig Editore, 1986. - P. 83-88.

Joseph T., Fajadet J., Laurent J.-P. et al. Implantation d’endoprothéses coronaires chez les patients diabétiques // Arch. Mal. Coeur Vaissen. – 1998. – T. 91, № 6. – P. 715-720.

Juhlin P., Boström P.-Å., Torp A., Bredberg A. Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction // J. Intern. Med. – 1999. – Vol. 245, № 5. – P. 483-488.

Junker C., Hönig M., Hörmann K. Gigantischer Tumor der äusseren Nase // HNO. - 1997. - Vol. 45, № 8. - P. 636-637.

Jurado A., Cardaba B., Jara P. et al. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens // J. Hepatol. - 1997. - Vol. 26, № 5. - P. 983-992.

Kahaly G., Pitz S., Műller-Forell W., Hommel G. et al. Randomized trial of intravenous immunoglobulins versus prednisolone in Grave’ ophthalmopathy // Clin. Exp. Immunol. - 1996. - Vol. 106, № 2. - P. 197-202.

Kahn S.E., Andrikopoulos S., Verchere C.B. Islet amyloid. A long-recognized but underappreciated pathological feature of type 2 diabetes // Diabetes. - 1999. – Vol. 48, № 2. – P. 241-253.

402

Kakker A.K., Williamson R.C.N. Thromboprophylaxis in the cancer patient // Haemostasis. – 1998. – Vol. 28, Suppl. 3. – P. 61-65.

Kamei A., Ichiuche S., Onuma R. et al. Acute disseminated demyelination due to primary human herpesvirus-6 infection // Eur. J. Pediatr. - 1997. - Vol. 156, № 9. - P. - 709-712.

Kamimura M., Matsuo M., Miyahara T et al. Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease // Ther. Apher. Dial. – 2002. – Vol. 2, № 6. – P. 467-470.

Kaminuma O., Mori A., Ogawa K. et al. Cloned Th cells confer eosinophilic infiltration and bronchial hyperresponsiveness // Int. Arch. Allergy Immunol. – 1999. – Vol. 118, № 2-4. – P. 136-139.

Kamiyama T., Nouchi T., Koijma S. et al. Autoimmune hepatitis triggered by administration of an herbal medicine // Am. J. Gastroenterol. - 1997. - Vol. 92, № 4. - P. 703-705.

Kandiah D.A., Sali A., Sheng Y. et al. Current insight into the “antiphospholipid” syndrome: clinical, immunological, and molecular aspects // Adv. Immunol. – 1998. – Vol. 70. – P. 507-563.

Kaneto H., Kajimoto Y., Miyagava J. et al. Beneficial effects of antioxidants in diabetes. Possible protection of pancreatic β-cells against glucose toxicity // Diabetes. – 1999. – Vol. 48, № 12. – P. 2398-2406.

Karges W., Hammond-McKibben D., Gaedigk R. et al. Loss of self-tolerance to ICA69 in nonobese diabetic mice // Diabetes. - 1997. - Vol. 46, № 10. - P. - 1548-1556.

Kariakidis A.V., Karydakis P., Neofytou N. et al. Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases // Pancteatology. – 2005.

– Vol. 5, № 2-3. – P. 201-204.

Karmochkine M., Kazatchkine M.D. Intravenous immune globulin in autoimmune uveitis // Ann. Intern. Med. - 1998. - Vol. 129, № 12. - P. 1078-1079.

Karp C.L. Interleukin-12: amiss in MS // Ann. Neurol. – 1999. – Vol. 45, № 6. – P. 689-692.

Kashimoto C., Kitazawa M., Hiraoka Y., Takada H. Extracellular matrix remodeling in coxsackievirus B3 myocarditis // Clin. Immunol. Immunopathol. - 1997. - Vol. 85, № 1. - P. - 47-55.

Kawamura A. Therapeutic apheresis in Japan // Ther. Apher. Dial. – 2003. – Vol. 7, № 6. – P. 497.

Kawasaki S., Nishida K., Quantock A.J. et al. Amyloid and pro 501thr-mutated βigh3 gene product colocakize in lattice corneal dystrophy type IIIA // Am. J. Ophthalmol. - 1999. - Vol. 127, № 4. - P. 456-458.

Kaynar L., Altuntas F., Aydoglu I. et al. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study // Transfus. Apher. Sci. – 2008. – Vol. 38, № 2. – P. 109-115.

403

Kazatchkine M.D. Delineating physiological (natural) autoreactivity from pathological autoimmunity // Vox Sang. - 1996. - Vol. 70 Suppl. 1. - P. 24-29.

Keren A., Hayes H.M., O’Driscoll G. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab // Transplant. Proc.

– 2006 . – Vol. 38, № 5. – P. 1520-1522.

Kevy S.V., Fosburg M., Woffe L. Intensive plasma exchange in pediatrics // Plasma therapy. Transfustechnick. - 1984. - Vol. 5, № 2. - P. 199-205.

Kfoury-Baz E.M., Nassar R.A., Tanios R.F. et al. Plasmapheresis in asparaginaseinduced hypertriglyceridemia // Transfusion. – 2008. – Vol. 48, № 6. – P. 1227-1230.

Khatri B.O., McQuillen M.P., Hoffman R.G. Plasma exchange in chronic progressive multiple sclerosis. A long term study // Neurology. - 1991. - Vol. 41, № 4. - P. 409-414.

Khuroo M.S., Khuroo M.S., Farahat L.C. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis // Liver Transplant. – 2004.

– Vol. 10. – P. 1099-1106.

Kiefersauer S., Reiter Ch., Diepolder H.M. et al. Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in patient with chronic hepatitis C // J. Immunol. - 1997. - Vol. 159, № 8. - P. - 4064-4071.

Kikuchi H., Marujama H., Omori S. et al. The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification // Ther. Apher. Dial. – 2003. – Vol. 7, № 4. – P. 456-460.

Kim W.R., Poterucha J.J., Hermans J.E. Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis C // Ann. Intern. Med. - 1977. - Vol. 127, № 10. - Зю - 866-874.

Kincaid J.C. Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies // Ther. Apher. Dial. – 2002. – Vol. 6, № 1. – P. 53-56.

Kirchner T., Steiniger H., Faller G. Immunopathology of Helicobacter pilory gastritis // Digestion. - 1997. - Vol. 58, Suppl. 1. - P. 14-16.

Klebanov S., Herlihy J.T., Freeman G.L. Effect of long-term food restriction on cardiac mechanics // Am. J. Physiol. - 1997. - Vol. 273, № 5 Pt 2. - P. H2333-H2342.

Klein H.G. Principles of apheresis / In: Anderson K.C., Ness P.M. (eds). Scientific basis of transfusion medicine. Philadelphia: W.B.Saunders. – 1994. – P. – 781-796.

Klingel R., Fassbender T., Fassbender C., Göhlen B. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis // Ther. Apher. Dial. – 2003. – Vol. 7, № 3. – P. 350-358.

Klingel R., Mumme Ch., Fassbender T. et al. Rheoferesis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial // Ther. Apher. Dial. – 2003. – Vol. 7, № 4. – P. 444-455.

404

Klingel R., Mausfeld P., Fassbender C., Goehlen B. Lipidfiltration – safe and effective methodology to perform lipid-apheresis // Transfus. Apher. Sci. – 2004. – Vol.

30.– P. 245-254.

Klingel R., Erdtracht B., Gauss V. et al. Rheopheresis in patients with critical limb

ischemia – results of an open label prospective pilot trial // Ther. Apher. Dial. – 2005. – Vol. 9, № 6. – P. 473-481.

Knip M. Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus // Ann. Med. - 1997. - Vol. 29, № 5. -P. 447-451.

Kobayashi A., Nakatani M., Furuyoshi S., Nani M. In vitro evaluation of dextran sulphate cellulose beads for whole blood infusion low-density lipoproteinhemoperfusion // Ther. Apher. – 2002. – V. 6, № 6. – P. 365-371.

Kodama M., Tani T., Nakane Y. [Plasmapheresis in the patients with malignant tumor] // Gan To Kagaku Ryoho. – 1984. – Vol. 11, № 7. – P. 1349-1355.

Koehler P.J., Kondstaal J. Lethal hypersensitivity myocarditis associated with the use of intravenous gammaglobulin for Guillain-Barré syndrome, in combination with phenitoin // Neurology. - 1996. - Vol. 243, № 4. - P. 366-367.

Kojima S. Low-density lipoprotein apheresis and changes in plasma components // Ther. Apher. – 2001. – Vol. 5, № 4. – P. 232-238.

Koga N. The role of low-density lipoprotein apheresis in the treatment of hypercholesterolemia and aterosclerosis // Ther. Apher. – 2001. – V. 5, № 4. – P. 219.

Kolla S., Awad S.S., Rich P.B. et al. Extracorporeal life support for 100 adult patients with severe respiratory failure // Thorax. - 1997. - Vol. 226, № 4. - P. - 544564.

Kolsal E., Tekin I.O., Piskin E. et al. Treatment of severe amitriptyline intoxication with plasmapheresis // J. Clin. Apher. – 2009. – Vol. 24, № 1. – P. 21-24.

Kon O.M., Kay A.B. T cells and chronic asthma // Int. Arch. Allergy Immunol. – 1999.

– Vol. 118, № 2-4. – P. 133-135.

Konishi T. [Plasmapheresis in patients with myasthenia gravis] // Nippon Rinsho. – 2008. – Vol. 66, № 6. – P. 1165-1171.

Konstantinov K., von Mikaez A., Buchwald D. et al. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome // J. Clin. Invest. - 1996. - Vol. 98, № 8. - P. – 1888-1889.

Korach J-M., Guillevin L., Petitpas D. et al. Apheresis registry in France: indications, techniques, and complications // Ther. Apher. – 2000. – Vol. 4, № 3. – P. 207-210.

Kornberg A.J., Pertronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. -S43-50.

Körner H., Riminton D.S., Stickland D.H. et al. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting // J. Exp. Med. - 1997. - Vol. 186, № 9. - P. - 1585-1590.

405

Kornfeld D., Cnattingius S., Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - A population-based cohort study // Am. J. Obstet. Gynecol. - 1997. - Vol. 177, № 4. - P. 942-946.

Korpilahti K., Syvänne M., Engblom E. et al. Components of the insulin resistance syndrome are associated with progression of atherosclerosis in non-grafted arteries 5 years after coronary artery bypass surgery // Eur. Heart J. - 1998. - Vol. 19, № 5. - P. 711-719.

Kozaki K., Egawa H., Ueda M. et al. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience // Ther. Apher. Dial. – 2006. – Vol. 10, № 5. – P. 441-448.

Kramer R., Oberg-Higgins P., Russo L., Braxton J.H. Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis // Interact. Cardiovasc. Thorac. Surg. – 2009. – Vol. 8, № 4. – P. 439-441.

Krawitt E.L., Porta G. Autoimmine hepatitis. - in: Therapy of digestive disorders . – W.B.Saunders Co, Philadelphia, 2000. – P. 307-314.

Krebs A., Krebs K., Keller F. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2002 // Int. J. Artif. Organs. – 2004. – Vol. 27. – P. 137-148.

Krishna M.T., Mudway I., Kelly F.J. et al. Ozone, airways and allergic airways disease // Clin. Exp. Allergy. - 1995. - Vol. 25, № 12. - P. 1150-1158.

Krishna M.T., Springall D., Meng Q.-H. et al. Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans // Am. J. Respir. Crit. Care Med. - 1997. - Vol. 156, № 3. - P. - 943-950.

Krnie-Barrie S., O’Connor C.R., Looney S.W. et al. A retrospective review of 61 patient with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis // Arch. Intern. Med. - 1997. - Vol. 157, № 18. - P. - 2101-2108.

Krumpaszky H.G., Lüdtke R., Mickler A. et al. Blindness incidence in Germany. A population-based study from Würtemberg-Hohenzollern // Ophthalmologica. – 1999. – Vol. 213, № 3. – P. 176-182.

Kuang W., Tan J., Yuan X. et al. Plasma exchange therapy holds promise in the management of advanced cancer // Med. Hypotheses. – 2009. – Vol. 72, № 5. – P. 533534.

Kutteh W.H., Yetman D.L., Carr A.C. et al. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction // Fertil. Steril. - 1999. - Vol. 71, № 5. - P. 843-848.

Kutteh W.H., Park V.M., Deicher S.R. Hypercoagulable state mutation and lysis in white patients with early first-trimestr recurrent pregnancy loss // Fertil. Steril. – 1999. – Vol. 71, № 6. – P. 1048-1053.

Kuusisto J., Koivisto K., Mykkänen L. et al. Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein

406

E4 phenotipe: cross sectional population based study // Brit. Med. J. - 1997. - Vol. 315, № 7115. - P. 1045-1049.

Kyndt X., Reumaux D., Bridoux F. et al. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis // Am. J. Med. – 1999. – Vol. 106, № 5. – P. 527-533.

Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes // Diabetes. - 1999. - Vol. 48, № 5. - P. 937-942.

Laing P. The development and complications of diabetic foot ulcers // Am. J. Surg. - 1998. - Vol. 176, № 2A Suppl. - P. 11-19.

Lalmuanluii J., Yalamanchii K., Fircanis S., Nelson J.C. Hypersensitivity to plasma exchange in patient with thrombotic thrombocytopenic purpura // J. Clin. Apher. 2009. – 2009. – Vol. 24, № 1. – P. 18-20.

Lammie G.A., Brannan F., Slattery J., Warlow Ch. Nonhypertensive cerebral smallvessel disease. An autopsy study // Stroke. - 1997. - Vol. 28, № 11. - P. 2222-2229.

Landini S. Plasma exchange in severe leptospirosis. - Plasmapheresis: Therapeutic Applications and New Techniques. - N.-Y., 1983. - 488 p.

Landtblom A.M., Lindval B., Ledin T., Berlin G. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titres // Ther. Apher. Dial. – 2008. – Vol. 12, № 1. – P. 82-85.

Laskin C.A., Bombardier C., Hannan M.E. et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss // New. Engl. J. Med. - 1997. - Vol. 337, № 3. - P. 148-153.

Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammapathy // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. - P. S32-42.

Latremouille Ch., Genevaz D., Hu M.C. et al. Normal Human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection thrugh F(ab’)2-mediated anti-complement activity // Clin. Exp. Immunol. - 1997. - Vol. 110, № 1. - P. - 122-126.

Lee J.C., Cevallos A.M., Naeem A. et al. Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells // Gut. – 1999. – Vol. 44, № 2. – P. 196-202.

Lee M. The aging stomach: implications for NSAID gastropathy // Gut. - 1997. - Vol. 41, № 4. - P. 425-426.

Lee A.T., Reis D., Eriksson U.J. et al. Hyperglycemia-induced embrionic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo // Diabetes. – 1999. – Vol. 48, № 2. – P. 371-376.

Lee Y.-M., Kaplan M.M. Management of primary biliary cyrrhosis. - in: Therapy of digestive disorders . – W.B.Saunders Co, Philadelphia, 2000. – P. 349-354.

Lefaucheur C., Nochy D., Andrade J. et al. Comparison of combination plasmapheresis/IVIg/antiCD20 versus high-dose IVIg in the treatment of antibodymediated rejection // Am. J. Transplant. – 2009. – Vol. 9, № 5. – P. 1099-1107.

407

Lefrére J.J., Ravera N., Corbi C. et al. Infection with hepatitis G virus in immunoglobulin recepients // Lancet. - 1997. - Vol. 349, № 9046. - P. 206.

Lehto S., Niskanen L., Ronnemaa T., Laakso M. Serum uric acid is strong predictor of syroke in patients with noninsulin-dependent diabetes mellitus // Stroke. – 1998. – № 29. – З. 635-639.

Le Maoult J., Delassus S., Dyall R. et al. Clonal expansion of B lymphocytes in old mice // J. Immunology. - 1997. - Vol. 159, № 8. - P. - 3866-3874.

Lentz M.R., Gatanaga T., Wang C. Purification and characterization of inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients // Proc Natl Acad Sci USA . – 1990. – Vol. 87. – P. 8781-8784.

Lentz M.R., Hubbard W., Fischer C. Low molecular weight protein apheresis and regression of brest cancer // Jpn J Apheresis. – 1997. – Vol. 16, № 1. – P. 107-114.

Lentz M.R. The role of therapeutic apheresis in the treatment of cancer: a review // Therapeutic apheresis. – 1999. - Vol. 3, № 1. - P. 40-49.

Lenz W. Epidemiology of congenital malformations // Ann. N.Y., Acad. Sci. - 1965. - Vol. 123. - P. 228-236.

Lesko S.M., Mitchell A.A. Renal function after short-term ibuprofen use in infants and children // Pediatrics. - 1997. - Vol. 100, № 6. - P. 954-957.

Leslie R.D.G., Pyke D.A. Insulin dependent diabetes is probably due to environmental effect during childhood // B. M. J. – 1997. – Vol. 315, № 7114. – P. 1017.

Leung D.Y.M. Atopic dermatitis: immunobiology and treatment with immune modulators // Clin. Exp. Immunol. - 1997. - Vol. 107, Suppl. 1. - P. 25-30.

Levey A.I., Heilman C.J., Lah J.J.. Nash N.R. et al. Presenilin-1 protein expression in familial and sporadic Alzheimer’s disease // Ann. Neurol. - 1977. - Vol. 41, № 6. - P. 742-753.

Lewis E.J., Hunsicker L.G., LAN S.-P. et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis // New Engl. J. Med. - 1992. - Vol. 326, № 21. - P. 1373-1379.

Levis R.A., Selwa J.F., Lisak R.P. Myasthenia gravis: immunological mechanisms and immunotherapy // Ann. Neurol. - 1995. - Vol. 37, Suppl. 1. - P. S51-S62.

Leys K., Lang B., Johnston I., Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome // Ann. Neurol. - 1991. - Vol. 29, № 3. - P. 307-314.

Li H., Matheny M., Nicolson M. et al. Leptin gene expression increases with age independent of increasing adiposity in rats // Diabetes. - 1977. - Vol. 46, № 12. - P. 2035-2039.

Li L.J., Liu X.L., Xu X.W. et al. Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis // Ther. Apher. Dial. – 2005. – Vol. 9, № 5. – P.396-401.

408

Liao Y.H. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy // Int. J. Cardiol. - 1996. - Vol. 54, № 2. - P. 165-169.

Libshitz H.I. Effects of treatment on normal tissues // Abstr. 10th European Congress of Radiology. - Amsterdam, 1997. - P. 559.

Lick S.D., Vaidya S., Kollar A.C. et al. Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support // J. Heart Lung Transplant. – 2008. – Vol. 27, № 9. – P. 1036-1039.

Liebowitz R.S. Deep venous thrombosis. Thinking inside out // Arch. Intern. Med. – 1998. – Vol. 158, № 18. – P. 1964-1966.

Limas C.J. Cardiac autoantibodies in dilated cardiomyopathy. A pathogenetic role? // Circulation. - 1997. - Vol. 95, № 8. - P. 1979-1980.

Lindstrom J.M., Seybold M.E., Lenon V.A. et al. Antibody to acetylcholine receptor in myastenia gravis: prevalence, clinical correlates, and diagnostic value // Neurology. - 1998. - Vol. 51, № 4. - P. 933.

Little M.P., de Vathaire F., Shamsaldin A. et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy // Int. J. Cancer. – 1998. – Vol. 78, № 3. – P. 269-275.

Liu B-F., Miyata S., Kojima H. et al. Low phagocytic activity of resident peritoneal macrophages in diabetic mice. Relevance to the formation of advanced glycation end products // Diabetes. – 1999. – Vol. 48, № 10. – P. 2074-2082.

Livasy C.A., Kaplan A.M. Ciprofloxacin-induced toxic epidermal necrolysis: a case report // Dermatology. - 1997. - Vol. 195, № 2. - P. 173-175.

Lopate G., Parks B.J., Goldstein J.M. et al. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins // J. Neurol. Neurosurg. Psychiatry. - 1997. - Vol. 62, № 6. - P. 581-585.

Lockwood C.J., Romero R. et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population // Am. J. Obstet. Gynecol. - 1989. - Vol. 161, № 2. - P. 369-373.

Lopes-Virella M.F., Virella G. Atherosclerosis and autoimmunity // Clin. Immunol. Immunopathol. - 1994, Vol. 73, № 2. - P. - 155-167.

Ludwig B., Ochsebein A.F., Odermatt B. et al. Immunotherapy with dendritic cells directed against tumorantigens shared with normal host cells results in severe autoimmune disease // Allergologie. – 2000. – V. 23, № 3. – P. 131.

Luft F.C. Are plasminogen antibodies in rheumatoid arthritis of pathogenic significance? // J. Mol. Med. - 1996. - Vol. 74, № 8. - P. 413-414.

Lundin K.E. Cross-reacting antibodies in coeliac disease // Gut. – 1999. – Vol. 44, № 2. – P. 151-152.

409

Luther H-P., Homuth V., Wallukat G. α1-adrenergetic receptor antibodies in patients with primary hypertension // Hypertension. - 1997. - Vol. 29, № 2. - P. 678-682.

Lyi R.-K., Chen W.-H., Hsieh S.-T. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome // Ther. Apher. – 2002. – Vol. 6, № 2. – P. 163-166.

Mackay I.R. The problem of persisting destructive disease of the liver // Gastroenterology. – 1961. – Vol. 40, № 5. – P. 617-626.

Madrid A., Gil-Peralta A., Gil-Néсig E. et al. Morvan’ s fibrillary chorea: remission after plasmapheresis // J. Neurol. - 1996. - Vol. 243, № 4. - P. 350-353.

Majorga C., Luque G., Romero F. et al. Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferonbeta // Int. Arch. Allergy Immunol. – 1999. – Vol. 118, № 2-4. – P. 368-371.

Mäki M. Tissue transglutaminasae as the autoantigen of coeliac disease // Gut. - 1997. - Vol. 41, № 4. - P. 565-566.

Malfertheiner P., Mielke S. Helicobacter pilory infection in ulcer pathogenesis // Digestion. - 1997. - Vol. 58, Suppl. 1. - P. 17-20.

Mafenson H.L., Grunster J., Horowitz Q. Hasards of maternally administred drugs // Clin. Toxicol. - 1974. - Vol. 7, № 1. - P. 59-68.

Malozowski S., Purucker M., Worobec A. Cushing’s syndrome induced by betametasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation // B. M. J. – 1999. – Vol. 318, № 7194. – P. 1355.

Mandenhall C.L. Treatment of alcoholic liver disease . - in: Therapy of digestive disorders . – W.B.Saunders Co, Philadelphia, 2000. – P. 323-333.

Mann D.M.A. Molecular biology’s impact on our understanding of aging // Brit. Med. J. - 1997. - Vol. 315, № 7115. - P. 1078-1081.

Mantov S., Raev D. Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis // Int. J. Cardiol. - 1996. - Vol. 56, № 2. - P. 145-148.

Manns M.P. Autoantibodies in chronic hepatitis: Diagnostic reagents and scientific tools to study etiology, pathogenesis and cell biology // Progr. Liver. Dis. - 1994. - Vol.

12.- P. 137-156.

Marcelin A.-G., Dupin N., Bouscary D. et al. HHV-8 and multiple myeloma in France

// Lancet. - 1997. - Vol. 350, № 9085. - P. -1144.

Marin D.B., Breuer B., Marin M.L. et al. The relationship between apolipoprotein E, dementia, and vascular ilness // Atherosclerosis. - 1998. - Vol. 140, № 1. - P. 173-180.

Marthur S.K., Bhargava P. Insulin resistans and skin tags // Dermatology. - 1997. - Vol. 195, № 2. - P. - 184.

Martinu T., Chen D.F., Palmer S.M. Acute rejection and humoral sensitization in lung transplant recipients // Proc. Am. Thorac. Soc. – 2009. – Vol. 6, № 1. – P. 54-65.

410

Marwick C. Hepatitis C is focus of NIH consensus panel // JAMA. - 1997. - Vol. 277, № 16. - Р. 1268-1269.

Marzo M.E., Tintoré M., Fabregues O. et al. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α // J. Neurol. Neurosurg. Psychiatry. - 1998. - Vol. 65, № 4. - P. 604.

Mascaró J.M., Espaňa A., Liu Z. et al. Mechanisms of acantholysis in pemphigus foliaceus // Clin. Immunol. Immunopathol. - 1997. - Vol. 85, № 1. - P. - 90—96.

Mastriani J.A., Nixon R., Layzer R. et al. Prion protein conformation in patients with sporadic fatal insomnia // New Engl. J. Med. - 1999. - Vol. 340, № 21. - P. 1630-1638.

Mathias A., Wax J.R., Pinette M.G. et al. Progressive familial cholestasis complicating pregnancy // Matern. Fetal. Neonatal. Med. – 2009. – № 1. – P. 1-3.

Matsubara E., Ghiso J., Frangione B. et al. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer’s disease and Down’s syndrome // Ann. Neurol. - 1999. - Vol. 45, № 5. - P. 537-541.

Matsuda Y., Tsuda H., Takasaki Y., Hashimoto H. Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of C-reactive protein // Ther. Apher. Dial. – 2004. – Vol. 8, № 5. – P. 404-408.

Matsumori A., Ohashi N., Sasayma S. et al. Hepatitis C virus and hypertrophic cardiomyopathy // Ann. Intern. Med. – 1998. – Vol. 129, № 9. – P. 749-750.

Matsuno N., Iwamoto H., Nakamura Y. et al. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma // Transplant. Proc. – 2008. – Vol. 40, № 8. – P. 2497-2500.

Mattock M.B., Barness D.J., Viberti GC. et al. Microalbuminuria and coronary heart disease in NIDDM. An incidence study // Diabetes. – 1998. – Vol. 47, № 11. – P. 17861792.

Mattson M.P. Cellular actions of β-amyloid precrusor protein and its soluble and fibrillogenic derivates // Physiol. Rev. - 1997. - Vol. 77, № 4. - P. 1081-1132.

Mayer M.M. The cytolytic attack mechanism of complement // Allergy. – 1977. – Vol. 32, № 12. – P. 1-12.

Mayr M., Metzler B., Kiechl S. et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Esherichia coli and Chlamydia pneumoniae. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis // Circulation. – 1999. – Vol. 99, № 12. – P. 1560-1566.

Mazzanti L., Robini R.A., Fumelli P. et al. Altered platelet membrane dynamic properties in type 1 diabetes // Diabetes. - 1997. - Vol. 46, № 12. - P. 2069-2074.

McFarlane I.G. ANCAs away // Gut. – 1999. – Vol. 44, № 6. – P. 776-777.

McElhaney R.D., Ringer M., DeHart D.J., Vasilenko P. Rubella immunity in cohort of pregnant women // Infect. Control. Hosp. Epidemiol. - 1999. - Vol. 20, № 1. - P. 66.

Mecocci P., Polidori M.C., Ingegni T. et al. Oxidative damage to DNA in lymphocytes from AD patients // Neurology. – 1998. – Vol. 51, № 4. – P. 1014-1017.